Clinic
Christus Spohn Health System Corporation
Christus Spohn Health System Corporation was paid $17.62M by Medicaid between Jan 2019 and Dec 2024, across 109 billing codes. Its largest line is 99284, emergency room visit (serious) — 73% of everything it billed.
33Billing provider infoCHRISTUS SPOHN HEALTH SYSTEM CORPORATION
CORPUS CHRISTI, TX 78404
CORPUS CHRISTI, TX 78404
33aNPI1689641680assigned 03/08/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$17.62M
24GClaims252,342
24DCodes billed109
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#26 of 320
Median peer was paid$205K
This provider vs. median86×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 449 | $8K | |
| 2020 | 4,257 | $245K | |
| 2021 | 57,766 | $2.66M | |
| 2022 | 78,459 | $5.04M | |
| 2023 | 83,658 | $7.50M | |
| 2024incomplete | 27,753 | $2.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 73% | 18,494 | 17,275 | $12.82M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.1% | 2,335 | 2,122 | $890K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.9% | 9,542 | 8,607 | $687K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.7% | 14,862 | 14,021 | $654K |
| 80053 | Comprehensive metabolic panel | 2.1% | 29,105 | 25,566 | $363K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1.9% | 73 | 73 | $330K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 32,005 | 27,771 | $268K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 7,591 | 6,706 | $240K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 4,294 | 4,087 | $152K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 777 | 749 | $135K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,183 | 4,753 | $116K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,019 | 2,575 | $108K |
97 more codes
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 350 | $85K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,641 | $61K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 201 | $57K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 434 | $55K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 534 | $50K |
| 93976 | <1% | 288 | $44K | |
| 83690 | <1% | 5,769 | $42K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,042 | $40K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 892 | $38K |
| 84703 | <1% | 3,842 | $37K | |
| 81001 | <1% | 9,171 | $37K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,173 | $35K |
| 67311 | <1% | 26 | $31K | |
| 93975 | <1% | 129 | $27K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,329 | $20K |
| 84702 | <1% | 1,331 | $19K | |
| 84484 | <1% | 3,323 | $17K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 250 | $14K |
| Q3014 | Telehealth originating site facility fee | <1% | 801 | $14K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 786 | $13K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 88 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 452 | $11K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,197 | $9K |
| 83880 | <1% | 1,050 | $8K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 691 | $7K |
| 86850 | <1% | 745 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,282 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 918 | $4K |
| 90686 | <1% | 348 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,276 | $4K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 454 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,185 | $4K |
| 87070 | <1% | 319 | $4K | |
| 81003 | <1% | 1,521 | $3K | |
| 86328 | <1% | 196 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,814 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,859 | $3K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,122 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,182 | $2K |
| 83735 | <1% | 1,252 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 37,072 | $2K |
| 83605 | <1% | 1,118 | $2K | |
| 87040 | <1% | 869 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 913 | $2K |
| 86900 | <1% | 1,315 | $2K | |
| 80061 | Lipid panel | <1% | 596 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 541 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 227 | $2K |
| 85730 | <1% | 1,885 | $2K | |
| 82077 | <1% | 371 | $2K | |
| 86901 | <1% | 1,301 | $2K | |
| 85610 | <1% | 2,205 | $1K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 691 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 59 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 666 | $976.26 |
| 87210 | <1% | 120 | $811.01 | |
| 81025 | <1% | 87 | $754.79 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 418 | $551.67 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 618 | $423.92 |
| 85027 | <1% | 295 | $416.05 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 183 | $351.85 |
| 82728 | <1% | 28 | $279.90 | |
| 87186 | <1% | 213 | $246.76 | |
| 84439 | <1% | 97 | $234.22 | |
| 86923 | <1% | 15 | $228.30 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 140 | $223.53 |
| 83550 | <1% | 36 | $223.44 | |
| 73030 | <1% | 14 | $200.46 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 906 | $182.88 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 79 | $172.33 |
| 83540 | <1% | 43 | $170.78 | |
| 84100 | <1% | 180 | $161.28 | |
| 86140 | <1% | 94 | $156.60 | |
| 87077 | <1% | 152 | $148.70 | |
| 85379 | <1% | 44 | $119.27 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 853 | $90.45 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 148 | $72.98 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 659 | $66.65 |
| 82607 | <1% | 13 | $63.35 | |
| 82746 | <1% | 12 | $61.75 | |
| 82550 | <1% | 19 | $54.70 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 485 | $36.86 |
| 87147 | <1% | 21 | $17.40 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 641 | $17.09 |
| 0011A | <1% | 24 | $15.00 | |
| A9270 | Non-covered item or service | <1% | 1,995 | $5.53 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 371 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 12 | $0.00 |
| 82962 | 0% | 3,995 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 757 | $0.00 |
| C1769 | Guide wire | 0% | 43 | $0.00 |
| L8699 | Prosthetic implant, not otherwise specified | 0% | 71 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 17 | $0.00 |
| 0012A | 0% | 22 | $0.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 13 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 25 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBLOW, OSBERT (CEO)
| Provider | Location | Paid |
|---|---|---|
| Christus Spohn Health System Corporation | Alice, TX | $10.46M |
| Christus Spohn Health System Corporation | Beeville, TX | $6.22M |
| Christus Spohn Health System Corporation | Kingsville, TX | $5.93M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.